Gosse Bote Bruinsma

Directeur Général chez FAAH Pharma, Inc.

Profil

Gosse Bote Bruinsma currently works at FAAH Pharma, Inc., as Chief Executive Officer and viDA Therapeutics, Inc., as Director.
Dr. Bruinsma also formerly worked at Axonyx, Inc., as President, Chief Executive Officer & Director in 2006, IDEA AG, as Chief Executive Officer & Member-Management Board from 2012 to 2014, Vivendy Therapeutics Ltd., as Chief Executive Officer from 2009 to 2013, Curidium Medica Ltd., as Executive Chairman from 2007 to 2009, Forest Laboratories, Inc., as Medical Director, GT Biopharma, Inc., as Director, ClinTrials Research, Inc., as Medical Director, VP-Medical & Regulatory Affairs, Agendia NV, as Director, Zambon Company SpA, as Medical Director-European Division, Opsona Therapeutics Ltd., as Non-Executive Director, Janssen Vaccines & Prevention BV, as Vice President-Development, and Chrysalis, as General Manager & Vice President-Development.
Dr. Bruinsma received his undergraduate degree from McGill University and doctorate degree from the University of Leiden.

Postes actifs de Gosse Bote Bruinsma

Sociétés	Poste	Début
FAAH Pharma, Inc.	Directeur Général	-
viDA Therapeutics, Inc.	Directeur/Membre du Conseil	-

Anciens postes connus de Gosse Bote Bruinsma

Sociétés	Poste	Fin
Vivendy Therapeutics Ltd.	Directeur/Membre du Conseil	10/03/2014
Curidium Medica Ltd.	Président	08/01/2009
Axonyx, Inc.	Directeur Général	06/10/2006
Janssen Vaccines & Prevention BV	Corporate Officer/Principal	-
ClinTrials Research, Inc.	Directeur Technique/Scientifique/R&D	-